Avera Pharmaceuticals, Inc. Prices Public Offering of Common Stock
1/17/2013 9:20:59 AM
More...
|
Avera Pharmaceuticals, Inc. Licenses From Cornell University a Proprietary Surgical Muscle Relaxant and Reversal Agent Compound for the Anesthesia Market
3/21/2007 12:33:37 PM
More...
|
Avera Pharmaceuticals, Inc. Completes Enrollment In Phase 2 Social Anxiety Disorder Study
9/25/2006 9:58:31 AM
More...
|
Avera Pharmaceuticals, Inc. Names Dinu Sen Chief Executive Officer
9/14/2006 9:42:59 AM
More...
|
Avera Pharmaceuticals, Inc. Completes Successful Phase 2 Study Of Gantacurium Chloride For Endotracheal Intubation
6/27/2006 12:10:50 PM
More...
|
Avera Pharmaceuticals, Inc. Raises $48 Million In Series C Venture Financing
10/19/2005 5:11:19 PM
More...
|
Avera Pharmaceuticals, Inc. Names Joao Siffert, M.D. As Vice President, Clinical Research And Development
10/19/2005 5:08:52 PM
More...
|